# Phase 5 status — Long-horizon health platform

## Source scope status: COMPLETE AND FINAL-HARDENED

Phase 5 implements the final planned product-platform layer without changing Human Health into a medical authority. A second source audit after the initial feature-complete review found and corrected additional portability, provenance, validation, integration and fail-closed storage issues.

### Implemented
- [x] user/clinician-entered preventive records and reminders with explicit provenance/provider fields
- [x] reminder due-state, enable/disable and atomic completion/repeat behaviour without invented screening/vaccination intervals
- [x] timezone-stable, month-end-clamped recurrence for explicitly entered repeat intervals
- [x] local clinician discussion export in Markdown/JSON with source-id separation, units and data-quality notes
- [x] complete archive v2 includes Phase 5 preventive/platform data; legacy v1 archives remain importable
- [x] complete import/delete rollback spans training, connected-health and Phase 5 platform stores
- [x] unreadable/partially corrupt Phase 5 data blocks normal mutation/export rather than being silently overwritten or omitted
- [x] capability-model validation registry with explicit intended use, limitations, evidence and fail-closed claim gates
- [x] validated claims require complete external-study evidence plus a distinct explicitly independent replication record
- [x] all current capability models remain experimental until real external evidence and replication are recorded
- [x] deterministic on-device personal baseline with no cross-user training, hidden medical prediction or automatic sharing
- [x] versioned scoped integration bundle contract
- [x] optional integration-host boundary requires explicit confirmation and reconstructs a scope-only payload before external sharing
- [x] regulatory escalation gate fails closed for ambiguous intended use
- [x] medication/insulin dosing and emergency-monitoring feature profiles remain blocked in the current product
- [x] dedicated `/platform/` route and global Platform shortcut
- [x] `/platform/` included in PWA/offline static checks
- [x] source tests for reminders, storage corruption, portability, clinician export, validation claims, personal baselines, integration scopes and regulatory gates
- [x] repository-ready end-to-end line-by-line code-review agent prompt

## Important validation distinction

The Phase 5 **validation framework** is source-complete. The existing capability models are not being falsely described as externally validated. Software now fails closed unless a recorded external study and a distinct independent replication satisfy the claim gate, but actual evidence quality/applicability still requires real research and specialist review outside this repository.

## Verification still required
- [ ] eligible Human Health Actions runner executes verification (#51/#82)
- [ ] TypeScript check
- [ ] complete unit-test suite
- [ ] production static build
- [ ] PWA checks including `/platform/`
- [ ] mobile/tablet/desktop Platform route QA
- [ ] keyboard/focus/labels/contrast review
- [ ] synthetic clinician-export review
- [ ] preventive persistence/complete/disable/delete/restore browser QA
- [ ] complete archive v1→v2 import, v2 round-trip and delete-all browser QA
- [ ] explicit integration-share QA if a host is connected
- [ ] regulatory-gate scenario review
- [ ] offline reload of `/platform/`

## Completion definition

Phase 5 source scope and final hardening are complete. It is **not release-verified** until executable/runtime gates pass, and no capability model is externally validated until appropriate real-world evidence exists. No production deployment or merge is implied by source completion.